Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,702,987
-
Total 13F shares
-
23,819,590
-
Share change
-
+3,232,656
-
Total reported value
-
$336,536,131
-
Put/Call ratio
-
85%
-
Price per share
-
$14.13
-
Number of holders
-
93
-
Value change
-
+$48,279,010
-
Number of buys
-
57
-
Number of sells
-
34
Institutional Holders of Altimmune, Inc. - Common Stock (ALT) as of Q1 2021
As of 31 Mar 2021,
Altimmune, Inc. - Common Stock (ALT) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,819,590 shares.
The largest 10 holders included
VR Adviser, LLC, STATE STREET CORP, BAKER BROS. ADVISORS LP, Capital World Investors, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., CITADEL ADVISORS LLC, CAAS CAPITAL MANAGEMENT LP, BlackRock Inc., and CREDIT SUISSE AG/.
This page lists
93
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.